Marc Criton, Chief Executive Officer MedXCell NKar at MedXCell SA

Marc Criton

Chef de Projet Santé Biotech at SATT AxLR | Greater Montpellier Metropolitan Area, France

Profile last verified July 2026
Research Verified Profile Greater Montpellier Metropolitan Area, France Paris Descartes
Verified

Work Email

***@libertysurf.fr

Last verified August 2026

Phone Number

+33*****

France • Mobile

Free account · No credit card · 5 profiles/month

Marc Criton Socials
Marc Criton Work Experience

Chief Executive Officer MedXCell NKar at MedXCell SA in November 2019 - Present

Chief Operating Officer CYTEA BIO at CYTEA|BIO in August 2020 - Present

Senior Project Manager & Business Development at SATT AxLR in April 2013 - November 2019

See more See less

Active Pharmaceutical Ingredients Manager at LABORATOIRES MAYOLY SPINDLER in January 2009 - April 2013

R&D Deputy Director at LABORATOIRES MAYOLY SPINDLER in October 2007 - January 2009

Active Pharmaceutical Manager at LABORATOIRES MAYOLY SPINDLER in April 1996 - October 2007

Assistant Professor of Therapeutic chemistry at Université de Genève in January 1993 - January 1996

Marc Criton Education

Paris Descartes, DU Auditor

Institut d'Administration des Entreprises, Master

Université Montpellier II, PhD

Marc Criton Skills
Pharmaceutical Industry GMP Biotechnology Pharmaceutics Technology Transfer Drug Discovery Organic Chemistry Chemistry R&D Analytical Chemistry Gastroenterology Medicinal Chemistry Transfert technologique BPF Recherche médicamenteuse Secteur pharmaceutique Biotechnologie Pharmaceutique Chimie analytique Sciences de la vie
About Marc Criton’s Current Company
SATT AxLR

CYTEA BIO is a pre-clinical stage biotech company developing therapeutic products by combining genetically unmodified effector cells and engineered targeting ligands. Its patented Pin™ Platform enables practically limitless combinations of effector mechanisms and targeting ligands for applications in oncology and immunology. CYTEA BIO is the first portfolio company of MedXCell, a European cell therapy venture builder with offices in Switzerland, France and the US. MedXCell focuses on technologies, techniques or novel applications in major diseases such as cancer, autoimmune, neurological and degenerative disorders, with the aim to turn promising academic ideas into commercially viable propositions.

Discover more about SATT AxLR
Marc Criton’s Colleagues
Hortense Courot

Hortense Courot

Montpellier, Occitanie, France

Ingénieure R&D

R&D Engineer at InnomuneCare Group
(Jan 2026 – Present)

Search similar profiles
Frequently asked questions about Marc Criton

What is Marc Criton email address?

Email Marc Criton at [email protected]. This email is the most updated Marc Criton's email found in 2026.

What is Marc Criton phone number?

Marc Criton phone number is +33 6 30 19 87 56.

How to contact Marc Criton?

To contact Marc Criton send an email to [email protected]. If you want to call Marc Criton try calling on +33 6 30 19 87 56.

What company does Marc Criton work for?

Marc Criton works for SATT AxLR.

What is Marc Criton's role at SATT AxLR?

Marc Criton is Chef de Projet Santé Biotech

What industry does Marc Criton work in?

Marc Criton works in the Research industry.

Find anyone, anywhere
with ContactOut today

Making remote or global hires? Connecting
with key decision-makers? We can help.

  • 40 emails / month
  • 3 phone numbers / month
  • Works on standard LinkedIn only
  • Work emails, personal emails,
    mobile numbers
* 1 user per company limit

No credit card required

Try ContactOut for Free